Influenza outcomes in patients with inflammatory joint diseases and DMARDs: how do they compare to those of COVID-19? | Annals of the Rheumatic Diseases

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

Podcasts
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Epidemiology

Influenza outcomes in patients with inflammatory joint diseases and DMARDs: how do they compare to those of COVID-19?

Online download statistics by month:

Online download statistics by month: November 2021 to March 2024

	Abstract	Full	Pdf
Nov 2021	385	393	140
Dec 2021	410	411	55
Jan 2022	158	156	25
Feb 2022	360	362	92
Mar 2022	270	273	90
Apr 2022	115	113	37
May 2022	65	67	21
Jun 2022	50	49	13
Jul 2022	61	59	15
Aug 2022	86	85	10
Sep 2022	66	67	24
Oct 2022	52	51	18
Nov 2022	53	51	17
Dec 2022	48	48	9
Jan 2023	55	55	11
Feb 2023	56	55	10
Mar 2023	37	37	12
Apr 2023	123	3	4
May 2023	92	71	12
Jun 2023	26	25	3
Jul 2023	38	38	10
Aug 2023	43	41	15
Sep 2023	26	24	7
Oct 2023	41	39	13
Nov 2023	59	53	19
Dec 2023	38	38	15
Jan 2024	38	37	9
Feb 2024	23	23	12
Mar 2024	30	30	32
Total	2904	2754	750